Publication date: 4 May 2017
Source:Cell Stem Cell, Volume 20, Issue 5
Author(s): Magali Saint-Geniez, Mariana Aparecida B. Rosales
Stem cell-based disease modeling is an emerging technology for the mechanistic study and therapeutic screening of complex ocular pathologies. In this issue of Cell Stem Cell, Saini et al. (2017) show that iPSC-derived RPE cells from age-related macular degeneration patients express increased levels of pro-inflammatory factors that can be normalized by the anti-aging drug nicotinamide.
Teaser
Stem cell-based disease modeling is an emerging technology for the mechanistic study and therapeutic screening of complex ocular pathologies. In this issue of Cell Stem Cell, Saini et al. (2017) show that iPSC-derived RPE cells from age-related macular degeneration patients express increased levels of pro-inflammatory factors that can be normalized by the anti-aging drug nicotinamide.http://ift.tt/2pfAh8i
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου